DRUG Bright Minds Biosciences Inc.
Healthcare$86.28+3.33%ClosedMarket Cap: $669.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.62
P/S
0.00
EV/EBITDA
-18.95
DCF Value
$8.58
FCF Yield
-2.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-20.7%
ROA
-8.8%
ROIC
-10.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | -Infinity% | $-15.6M | $-10.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-6.9M | $-7.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-5.7M | $-4.1M | $— | — |
| FY null | $0.00 | NaN% | $-13.9M | $-12.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.3M | $-5.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.4M | $-3.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.6M | $49.6K | $— | — |
| Q4 null | $0.00 | NaN% | $-791.3K | $-773.4K | $— | — |
| FY null | $0.00 | NaN% | $-2.8M | $-2.8M | $— | — |
| Q3 null | $0.00 | NaN% | $234.7K | $229.9K | $— | — |
| Q2 null | $0.00 | NaN% | $-558.1K | $-574.1K | $— | — |
| Q1 2024 | $0.00 | NaN% | $-1.7M | $-1.7M | $-0.44 | — |